Common Stock |
4.23M |
$63.3M |
$14.97 |
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
|
|
Common Stock |
4.12M |
$61.7M |
$14.97 |
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
|
|
Common Stock |
110K |
$1.65M |
$14.97 |
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
|
|
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Common Stock |
|
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Common Stock |
|
Series A Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Fund VI LP |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned |
Common Stock |
|
Series B Convertible Preferred Stock |
0 |
|
|
Oct 24, 2022 |
F-Prime Capital Partners Life Sciences Advisors Fund VI LP |
Common Stock |
|